Yutian Pan

Yutian Pan

Auto-generated profile, based on publicly available information

Yutian Pan

Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People's Republic of China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YFYuan Fang
Yuan Fang
STShengwang Tian
Shengwang Tian
YPYutian Pan
Yutian Pan
WLWei Li
Wei Li
QWQiming Wang
Qiming Wang
YSYongqian Shu
Yongqian Shu
Pyroptosis is an inflammatory form of cell death triggered by certain inflammasomes, leading to the cleavage of gasdermin D (GSDMD) and activation of inactive cytokines like IL-18 and IL-1β. Pyroptosis has been reported to be closely associated to some diseases like atherosclerosis and diabetic nephropathy. Recently, some studies found that pyroptosis can influence the proliferation, invasion and metastasis of tumor, which regulated by some non-coding RNAs and other molecules. Hence, we provided an overview of morphological and molecular characteristics of pyroptosis. We also focus on mechanism of regulating pyroptosis in tumor cells as well as the potential roles of pyroptosis in cancer to explore potential diagnostic markers in cancers contributing to the prevention and treatment in cancers.

27 March 2018 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
YPYutian Pan
Yutian Pan
PMPei Ma
Pei Ma
YLYu Liu
Yu Liu
WLWei Li
Wei Li
YSYongqian Shu
Yongqian Shu
First identified in 1974, m6A RNA methylation, which serves as a predominant internal modification of RNA in higher eukaryotes, has gained prodigious interest in recent years. Modifications of m6A are dynamic and reversible in mammalian cells, which have been proposed as another layer of epigenetic regulation similar to DNA and histone modifications. m6A RNA methylation is involved in all stages in the life cycle of RNA, ranging from RNA processing, through nuclear export, translation modulation to RNA degradation, which suggests its potential of influencing a plurality of aspects of RNA metabolism. All of the recent studies have pointed to a complicated regulation network of m6A modification in different tissues, cell lines, and space–time models. m6A methylation has been found to have an impact on tumor initiation and progression through various mechanisms. Furthermore, m6A RNA methylation has provided new opportunities for early stage diagnosis and treatment of cancers. Herein, we review the chemical basis of m6A RNA methylation, its multiple functions and potential significance in cancer.

23 February 2017 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
PMPei Ma
Pei Ma
YPYutian Pan
Yutian Pan
WLWei Li
Wei Li
CSChongqi Sun
Chongqi Sun
JLJie Liu
Jie Liu
YSYongqian Shu
Yongqian Shu
Extracellular vesicles (EVs) are small membranous vesicles secreted from numerous cell types and have been found involved in cell-to-cell communication by transferring noncoding RNAs (ncRNAs) including microRNAs, long noncoding RNAs, and circular RNAs. Emerging evidence shows that EV-associated ncRNAs play important roles in a wide range of diseases, particularly in cancer where they function through regulating protein expression of the pivotal genes that make contributions to tumorigenesis. Given their stability and abundance in serum, EV-associated ncRNAs can act as new diagnostic biomarkers and new therapeutic targets for cancer. Herein, we review the properties of EV-associated ncRNAs, their functions, and potential significance in cancer.